ACSL4 and neoplasm: In NSCLC, combining ROR1 CAR-T cells with ferroptosis inducers enhances tumor cell ferroptosis by increasing IFN-γ secretion, lipid peroxidation, and ACSL4 upregulation, thereby promoting robust antitumor responses (76).